A detailed history of Fulton Bank, N.A. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fulton Bank, N.A. holds 66,639 shares of BMY stock, worth $2.64 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
66,639
Previous 45,793 45.52%
Holding current value
$2.64 Million
Previous $2.35 Million 53.81%
% of portfolio
0.33%
Previous 0.24%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 10, 2024

BUY
$47.98 - $54.4 $1 Million - $1.13 Million
20,846 Added 45.52%
66,639 $3.61 Million
Q4 2023

Jan 04, 2024

SELL
$48.48 - $57.85 $146,942 - $175,343
-3,031 Reduced 6.21%
45,793 $2.35 Million
Q3 2023

Oct 04, 2023

BUY
$57.89 - $64.73 $164,233 - $183,639
2,837 Added 6.17%
48,824 $2.83 Million
Q2 2023

Jul 06, 2023

BUY
$63.71 - $70.74 $181,318 - $201,326
2,846 Added 6.6%
45,987 $2.94 Million
Q1 2023

Apr 06, 2023

BUY
$65.71 - $74.53 $3,548 - $4,024
54 Added 0.13%
43,141 $2.99 Million
Q4 2022

Jan 05, 2023

SELL
$68.48 - $81.09 $412,181 - $488,080
-6,019 Reduced 12.26%
43,087 $3.1 Million
Q3 2022

Oct 04, 2022

SELL
$0.13 - $76.84 $1,224 - $723,832
-9,420 Reduced 16.1%
49,106 $3.49 Million
Q2 2022

Jul 07, 2022

SELL
$72.62 - $79.98 $650,021 - $715,900
-8,951 Reduced 13.27%
58,526 $4.51 Million
Q1 2022

Apr 05, 2022

BUY
$61.48 - $73.72 $2.14 Million - $2.56 Million
34,773 Added 106.33%
67,477 $4.93 Million
Q4 2021

Jan 05, 2022

BUY
$53.63 - $62.52 $704,537 - $821,325
13,137 Added 67.14%
32,704 $2.04 Million
Q3 2021

Oct 05, 2021

BUY
$59.17 - $69.31 $317,742 - $372,194
5,370 Added 37.82%
19,567 $1.16 Million
Q2 2021

Jul 06, 2021

SELL
$61.91 - $67.42 $63,024 - $68,633
-1,018 Reduced 6.69%
14,197 $949,000
Q1 2021

Apr 05, 2021

SELL
$59.34 - $66.74 $979,406 - $1.1 Million
-16,505 Reduced 52.03%
15,215 $961,000
Q4 2020

Jan 07, 2021

SELL
$57.74 - $65.43 $103,008 - $116,727
-1,784 Reduced 5.32%
31,720 $1.97 Million
Q3 2020

Oct 06, 2020

BUY
$57.43 - $63.64 $468,513 - $519,175
8,158 Added 32.19%
33,504 $2.02 Million
Q2 2020

Jul 06, 2020

SELL
$54.82 - $64.09 $1.06 Million - $1.23 Million
-19,245 Reduced 43.16%
25,346 $1.49 Million
Q1 2020

Apr 03, 2020

BUY
$46.4 - $67.43 $84,355 - $122,587
1,818 Added 4.25%
44,591 $2.49 Million
Q4 2019

Jan 24, 2020

BUY
$49.21 - $64.19 $780,372 - $1.02 Million
15,858 Added 58.92%
42,773 $2.75 Million
Q3 2019

Oct 03, 2019

SELL
$42.77 - $50.71 $8,725 - $10,344
-204 Reduced 0.75%
26,915 $1.37 Million
Q2 2019

Jul 03, 2019

SELL
$44.62 - $49.34 $62,468 - $69,076
-1,400 Reduced 4.91%
27,119 $1.23 Million
Q1 2019

Apr 03, 2019

SELL
$45.12 - $53.8 $5,324 - $6,348
-118 Reduced 0.41%
28,519 $1.36 Million
Q4 2018

Jan 03, 2019

SELL
$48.76 - $63.23 $93,619 - $121,401
-1,920 Reduced 6.28%
28,637 $1.49 Million
Q3 2018

Oct 03, 2018

BUY
$55.19 - $62.25 $481,367 - $542,944
8,722 Added 39.95%
30,557 $1.9 Million
Q2 2018

Jul 10, 2018

SELL
$50.53 - $62.98 $7,731 - $9,635
-153 Reduced 0.7%
21,835 $1.21 Million
Q1 2018

May 02, 2018

SELL
$59.92 - $68.98 $44,400 - $51,114
-741 Reduced 3.26%
21,988 $1.39 Million
Q4 2017

Jan 04, 2018

BUY
$59.94 - $65.35 $68,571 - $74,760
1,144 Added 5.3%
22,729 $1.39 Million
Q3 2017

Oct 04, 2017

BUY
$55.23 - $63.74 $1.19 Million - $1.38 Million
21,585
21,585 $1.38 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $84.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Fulton Bank, N.A. Portfolio

Follow Fulton Bank, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Fulton Bank, N.A. with notifications on news.